Warthin's tumor is a benign monomorphic adenoma with unclear origin with the highest incidence in the sixth and seventh decades. The analysis of tumor markers involved in the pathogenesis of Warthin's tumor can improve the patients' prognosis. This study included 29 cases of Warthin's tumor, which were histopathologically and immunohistochemically examined for different compartments of tumors. For immunohistochemical study, we used as specific markers for epithelial compartment CD117, CEA and AMA, respectively S100 and D2-40 for the stromal compartment. The evaluation of immunoreactions was performed by semiquantitative analysis. The analysis of the CEA, CD117 and AAM immunoexpression allowed observing various patterns of immunostaining for tumor double-layered epithelia, which has the tendency of being similar to that in the normal ductal epithelia. S100 protein positivity similar to Langerhans cells suggests that delayed hypersensitivity can be involved in tumor development. The presence of D2-40 expression in majority of tumor subcapsular vessels, similar to lymph nodes structure, confirms the hypothesis that Warthin's tumor has its origin in regional lymph nodes.

Download full-text PDF

Source

Publication Analysis

Top Keywords

warthin's tumor
20
tumor
9
immunohistochemical study
8
lymph nodes
8
warthin's
5
study epithelial
4
epithelial stromal
4
stromal components
4
components warthin's
4
tumor warthin's
4

Similar Publications

The Impact of Inflammation on the Etiopathogenesis of Benign Salivary Gland Tumors: A Scoping Review.

Int J Mol Sci

November 2024

Department of Otolaryngology, Academy of Applied Medical and Social Sciences, 82-300 Elblag, Poland.

Salivary gland tumors are rare head and neck tumors constituting up to 6% of all head and neck neoplasms; despite being mostly benign, these tumors present in diverse histological subtypes, making them challenging to diagnose and treat. Our research aims to investigate the link between inflammation and tumorigenesis within the salivary glands based on the literature regarding the etiopathogenesis of benign salivary gland tumors. This scoping review was conducted following the PRISMA extension for scoping reviews and reporting guidelines.

View Article and Find Full Text PDF
Article Synopsis
  • Warthin's tumor is a common benign tumor in the parotid gland, often appearing in multiple places or in both glands at the same time in 20% - 30% of cases.
  • This case report highlights a rare instance of Warthin's tumor that occurred simultaneously in both parotid glands and outside the parotid area.
  • The low occurrence of such cases may be underestimated, and raising awareness could help doctors improve diagnosis and treatment for patients.
View Article and Find Full Text PDF

Purpose: BSND is a chloride channel subunit that is expressed in the normal salivary gland. We aimed to validate the utility of BSND immunohistochemistry in the differential diagnosis of oncocytic salivary gland neoplasms.

Methods: BSND immunohistochemistry was performed in a retrospective cohort of 93 salivary gland lesions, enriched with tumors with oncocytic features and histologic variants of mucoepidermoid carcinoma (MEC).

View Article and Find Full Text PDF

Warthin's tumor constitute a minority of salivary gland neoplasms. It is a monomorphic adenoma commonly involving the parotid gland and considered to be unique because of its histological appearance, unknown origin and pathogenesis. Large, bilateral Warthin's tumor of the parotid gland is clinically very rare.

View Article and Find Full Text PDF

Background: Extrapulmonary tuberculosis (TB) is a relatively rare form of tuberculosis infection, accounting for approximately 15% of all tuberculosis infections. Lymph nodes are the most commonly affected sites, while involvement of the parotid gland is extremely rare.

Case Presentation: We present the case of a 65-year-old male patient with a one-month history of a left parotid mass.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!